Moreover, it has been reported that a poorer prognosis in multiple myeloma is correlated with a lack of cKit, but also with beta-2 microglobulin, translocation t (4; 14), and CD221 (IGF-1R)51. The gene discussed is B2M; the disease is plasma cell myeloma.